← Back to headlines



Mindrank AI CEO Discusses Business Strategy and AI Drug Discovery
The founder and CEO of AI biotech firm Mindrank AI outlines the company's strategic focus on leveraging artificial intelligence for pharmaceutical development.
26 Aug, 03:53 — 26 Aug, 03:53
Related Stories

Global Outage Disrupts Microsoft Outlook Email Services
31m ago

Cathie Wood's ARK Invest Buys $53M in Nvidia, Sells Palantir and Buys Rocket Lab and Block
57m ago

FTC and 22 States Sue Amazon Over Alleged Advertising Price Manipulation
1h ago
Instagram cracks down on unlabeled AI influencers amid Nepal flood disinformation
6h ago